Figure 4
From: Denosumab for dialysis patients with osteoporosis: A cohort study
Comparison of Kaplan-Meier curves for incidence of hypocalcemia* in HD and non-HD patients. *Hypocalcemia was defined as decline of calcium >1.5 mg/dL or >1.0 mg/dL after an increased dose of active vitamin D and/or calcium carbonate.
